H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

類似資料

• A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
  著者:: P de Whalley, 等
  出版事項: (2011-12-01)
• Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
  著者:: CS Waddington, 等
  出版事項: (2010-10-01)
• Safety and immunogenicity of AS03(B) adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
  著者:: Waddington, Claire S, 等
  出版事項: (2010)
• Reactogenicity of pertussis vaccines.
  著者:: Cameron, J
  出版事項: (1978)
• Assessment of healthcare delivery in the early management of bacterial meningitis in UK young infants: an observational study
  著者:: Okike, Ifeanyichukwu O, 等
  出版事項: (2017)